india diabetes management devices market forecast report - 2020 brochure

10
India Adhesives Market Forecast & Opportunities, 2020 India Diabetes Management Devices Market Opportunities, 2010 - 2020 Pharma & Healthcare Consultants

Upload: pharmaion-consultants-pvt-ltd

Post on 14-Jan-2017

283 views

Category:

Health & Medicine


0 download

TRANSCRIPT

India Adhesives Market Forecast & Opportunities , 2020

India Diabetes Management Devices Market Opportunities , 2010 - 2020

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

R e s e a r c h M e t h o d o l o g y

2

© Pharmaion

Baseline Methodology :

For the study, Pharmaion has gathered information through primary research with respondents in medical

devices industry across India, followed by external validation of the information by interviewing marketing

individuals. We also gathered insights through an exhaustive search of credible paid databases and our internal

database. Our team of analysts has prudently evaluated all the collected information and presented the same in

chronological order to depict a meaningful and clear picture of diabetes management devices market in India.

While compiling the data, we have also validated all the collected information from multiple sources and data

warehouses, in order to present the most accurate and precise information of the concerned industry. The

information has then been verified through primary research surveys with competitors to arrive at logical

figures.

Sources :

Company Websites, Annual Reports, CBEC, International Diabetes Federation, WHO reports

Companies Interviewed

Medtronic India, Roche Diagnostics India, Bayer HealthCare, Abbott India Limited, LifeScan Inc., Biocon

Limited

T a b l e o f C o n t e n t s

3

© Pharmaion

S. No. Contents

1. Research Methodology

2. Analyst View

3. Product Overview - Diabetes Management Device

4. Disease Epidemiology

5. Global Diabetes Management Device Market Overview

6. India Diabetes Management Device Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

6.2.2. By End User

6.2.3. By Region

6.2.4. By Company

7. India Diabetes Monitoring Device Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Components/ Devices

7.2.2. By End User

8. India Diabetes Management Delivery Devices Market Outlook

T a b l e o f C o n t e n t s

4

© Pharmaion

S. No. Contents

8.1.

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By End User

9. Market Dynamics

9.1. Drivers

9.2. Challenges

10. Market Trends & Developments

10.1. Insulin Spray

10.2. Remote Diabetes Monitoring Device

10.3. Health App

10.4. Continuous Glucose Monitoring Device

10.5. Non Invasive/ Wearable Devices

11. Policy & Regulatory Landscape

12. India Economic Profile

13. Competitive Landscape

13.1. Competition Benchmarking (Market Attractiveness)

13.2. Company Profiles

13.2.1. Roche Diagnostics India Pvt. Ltd.

13.2.2. LifeScan India

13.2.3. Abbott India Limited

T a b l e o f C o n t e n t s

5

© Pharmaion

S. No. Contents

13.2.4. Bayer Healthcare

13.2.5. India Medtronic Pvt. Ltd.

13.2.6. ARKRAY Healthcare Pvt Ltd.

13.2.7. Eli lily And Company (India) Pvt Ltd

13.2.8. Sanofi India Limited

13.2.9. Novo Nordisk India

13.2.10. Biocon Limited

14. Strategic Recommendations

15. About Us & Disclaimer

I n d u s t r y B r i e f

6

© Pharmaion

India Diabetes Management Devices Market Poised to Grow at over 9% until 2020

Increasing disease burden and growing technological advancements to drive diabetes managementdevices market in India

According to the recently published Pharmaion report, "India Diabetes Management Devices MarketForecast & Opportunities, 2020”,diabetes management devices in India is projected to exhibit a CAGR ofover 9% during 2015 - 2020.Changing eating habits and sedentary lifestyle is increasing the prevalence ofdiabetes in the country, thereby driving the sales of diabetes management devices in India. Furthermore,surging domestic manufacturing of diabetes management devices is anticipated to play a significant role inboosting adoption of these devices in India in the coming years.

The market has been segmented into two broad categories, namely, diabetes monitoring devices anddiabetes management delivery devices. Among these device types, diabetes monitoring devices segmentis anticipated to continue its domination through 2020 on account of rising patient awareness regardingpreventive health care and introduction of compact, potable and user-friendly monitoring devices. During2015 - 2020, Southern region of India is expected to witness the highest growth on account of growingprevalence of diabetic cases and rising consumer awareness about using these devices in the region.

“In April 2015, Indian Government approved 100% FDI, through automatic route, in medical devicesmarket, which will allow the entry of foreign companies in diabetes management devices market. As aresult, the competition between market players is anticipated to increase, which is expected to bring downthe prices of these devices during the forecast period "said Mr. Karan Chechi, Research Director withPharmaion, a research based global pharmaceutical and healthcare consulting firm.

7

© Pharmaion

P r o d u c t O v e r v i e w

Insulin Pens

They are reusable or disposable pens which contains insulin in self contained cartridge. The

pens have a dialler for dosing and a needle to administer the insulin. There are two kinds of

insulin pens, namely, durable insulin pens and pre-filled insulin pen. Durable insulin pens are

mainly made up of metal and contain a replaceable insulin cartridge while pre-filled insulin pens

are disposable plastic pens that have a self-contained insulin cartridge and are to be disposed

off once the insulin is exhausted.

Insulin Syringe

They are disposable syringe containing needle, which is coated with special coating, such as

micro bonded lubrication for easy and painless administration. They are available in various

size barrels, needle lengths and needle thickness.

Insulin Pumps

They are small sized devices containing an insulin reservoir, which is connected to a small

catheter. The catheter is inserted in the abdomen or buttocks of the human body, and supplies

required amount of insulin to the body. Moreover, they monitor the level of insulin in the body

as well.

Others

Others includes Insulin sprays, Insulin jet injectors etc. Insulin sprays involves administration

of insulin into the body through nasal or buccal cavity in form of sprays. Insulin jet injectors

contains an insulin vial and a disposable injector nozzle, which delivers fine spray of insulin

under high air pressure, without using a needle. High pressure causes the insulin to vaporize

and the high pressure stream allows it to penetrate under the skin thereby entering the

bloodstream.

S a m p l e D a t a - S n a p s h o t

81 2 3 4 5

7 8 9 10 11 12

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

India Diabetes Management Devices Market

Size, By Value (USD Million), 2010-2020F

© Pharmaion

33.00% 33.01% 33.02% 33.03% 33.04% 33.05% 33.06% 33.07% 33.08% 33.09% 33.10%

65.00% 65.01% 65.02% 65.03% 65.04% 65.05% 65.06% 65.07% 65.08% 65.09% 65.10%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Diabetes Management Delivery Devices Diabetes Monitoring Devices

India Diabetes Management Devices Market Share, By Type, By Value, 2010-2020F

India Diabetes Management Devices Market

Share, By Region, By Value, 2010-2020F

EastNorth

South

West

2014 2020F

X% X%

2014 2020F

X% X%

2014 2020F

X% X%

2014 2020F

X% X%

Roche, 25.00%

Lifescan, 18.50%

Abbott, 20.00%Bayer,

20.0…

Arkray, 20.00%

Medtronic, 20.00%

Others*, 20.00%

India Diabetes Management Devices Market

Share, By Company, By Value, 2014

India Diabetes Management Devices Market

Share, By Company, By Value, 2020F

Roche, 15.00%

Lifescan, 15.00%

Abbott, 15.00%Bayer,

15.0…

Arkray, 15.00%

Medtronic, 15.00%

Others*, 10.00%

9

R e p o r t O r d e r i n g

License Type Price

Single User License $2500

Single User License Print $3000

Enterprise License $5000

To View Sample OR Purchase Report

Report Price

Report Name: India Diabetes Management Devices Market

Opportunities, 2010 - 2020

© Pharmaion

© Pharmaion

10

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

[email protected]

+1 646 360 1656

www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customerswith high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology asengines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trainedindustry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

India Stem Cell Market Forecast & Opportunities, 2020

Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020

Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020

Disclaimer

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

[email protected]

+91 - 120 - 452 3900

www.pharmaion.com